Intraocular pressure-lowering activity of NCX 470, a novel nitric oxide-donating bimatoprost in preclinical models. Impagnatiello F, Toris CB, Batugo M, Prasanna G, Borghi V, Bastia E, Ongini E, Krauss AH. Invest Ophthalmol Vis Sci. 2015;56(11):6558-64. http://iovs.arvojournals.org/article.aspx?articleid=2461805

---